10-K/A

FORM 10-K - AMENDMENT 3

Company: PharmaCyte Biotech, Inc.
Filed: March 2, 2016
Period of Report: April 30, 2015
Accession Number: 0001019687-16-005316

View Document ↗ View on SEC.gov ↗